Related references
Note: Only part of the references are listed.A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Asthma Control in Patients with Persistent Allergic Asthma
Jose Bardelas et al.
JOURNAL OF ASTHMA (2012)
Clinical Efficacy of Anti-IgE Therapy for Eosinophilic Otitis Media
Yukiko Iino et al.
OTOLOGY & NEUROTOLOGY (2012)
Monitoring free serum IgE in severe asthma patients treated with omalizumab
Stephanie Korn et al.
RESPIRATORY MEDICINE (2012)
Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease
Yukiko Iino et al.
AURIS NASUS LARYNX (2011)
Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma A Systematic Review
Gustavo J. Rodrigo et al.
CHEST (2011)
Changes in Total IgE Plasma Concentration Measured at the Third Month during Anti-IgE Treatment Predict Future Exacerbation Rates in Difficult-to-Treat Atopic Asthma: A Pilot Study
Roberto W. Dal Negro et al.
JOURNAL OF ASTHMA (2011)
The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells
Michael Roth et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Reduced Fc epsilon RI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy
Janet M. Oliver et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Eosinophilic Inflammation in the Middle Ear Induces Deterioration of Bone-Conduction Hearing Level in Patients With Eosinophilic Otitis Media
Yukiko Iino et al.
OTOLOGY & NEUROTOLOGY (2010)
Effects of omalizumab on markers of inflammation in patients with allergic asthma
S. Holgate et al.
ALLERGY (2009)
Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma
Oliver Noga et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media
Y Iino et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy
RG Hamilton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Immunological and clinical changes in allergic asthmatics following treatment with omalizumab
O Noga et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
Share Paper
